|
Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Trilipix (Fenofibrate) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Trilipix side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-07
Patient: male, weighing 85.7 kg (188.6 pounds)
Reactions: Renal Failure, Blood Potassium Increased, Thyroid Disorder, Diabetic Blindness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Tricor
Dosage: 145 mg, 1x/day
Administration route: Oral
Indication: Blood Cholesterol Increased
Glucotrol
Dosage: 10 mg, daily
Indication: Diabetes Mellitus
Start date: 1998-01-01
Lipitor
Indication: Cardiovascular Event Prophylaxis
Lipitor
Indication: Myocardial Infarction
Trilipix
Dosage: 45 mg, 1x/day
Administration route: Oral
Indication: Blood Cholesterol Increased
Lipitor
Dosage: 40 mg, 1x/day
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 1998-01-01
Other drugs received by patient: Omega-3 Triglycerides; Vitamin D; Glucotrol XL; Januvia; Acetylsalicylic Acid; Coenzyme Q10; Calcium Carbonate / Famotidine / Magnesium Hydroxide
|
